申请人:——
公开号:US20040209943A1
公开(公告)日:2004-10-21
The present invention relates to compounds of formula (I)
1
wherein R1, R2, R3, R4 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the antagonism of the glucagon receptor, such as diabetes.
本发明涉及式(I)1的化合物,其中R1、R2、R3、R4和n如描述和索赔中所定义,并且其药学上可接受的盐。这些化合物对于治疗和/或预防与胰高血糖素受体拮抗有关的疾病,如糖尿病,是有用的。